In addition, in three independent studies on multiple myeloma, ACTG1 was identified as one of the most frequently mutated genes in this hematological cancer involving plasma cells [13,14,15] and it even met the criteria for potentially being a candidate driver gene in multiple myeloma. This evidence concerns the gene ACTG1 and hematopoietic and lymphoid cell neoplasm.